Hologic Inc

HO1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HO1.DE stands at 0. In comparison, CBHD.DE has a market cap of 12.9B. Regarding current trading prices, HO1.DE is priced at €61.50, while CBHD.DE trades at €57.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HO1.DE currently has a P/E ratio of 86.74, whereas CBHD.DE's P/E ratio is 24.18. In terms of profitability, HO1.DE's ROE is +0.08%, compared to CBHD.DE's ROE of +0.25%. Regarding short-term risk, HO1.DE is less volatile compared to CBHD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for HO1.DE.Check CBHD.DE's competition here

HO1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HO1.DE stands at 0. In comparison, HS2.DE has a market cap of 9.4B. Regarding current trading prices, HO1.DE is priced at €61.50, while HS2.DE trades at €74.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HO1.DE currently has a P/E ratio of 86.74, whereas HS2.DE's P/E ratio is 22.93. In terms of profitability, HO1.DE's ROE is +0.08%, compared to HS2.DE's ROE of +0.12%. Regarding short-term risk, HO1.DE is more volatile compared to HS2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for HO1.DE.Check HS2.DE's competition here

HO1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HO1.DE stands at 0. In comparison, DY2.DE has a market cap of 3.8B. Regarding current trading prices, HO1.DE is priced at €61.50, while DY2.DE trades at €17.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HO1.DE currently has a P/E ratio of 86.74, whereas DY2.DE's P/E ratio is 8.34. In terms of profitability, HO1.DE's ROE is +0.08%, compared to DY2.DE's ROE of -0.24%. Regarding short-term risk, HO1.DE is more volatile compared to DY2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for HO1.DE.Check DY2.DE's competition here

HO1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HO1.DE stands at 0. In comparison, ZIM.DE has a market cap of 0. Regarding current trading prices, HO1.DE is priced at €61.50, while ZIM.DE trades at €94.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HO1.DE currently has a P/E ratio of 86.74, whereas ZIM.DE's P/E ratio is 233.84. In terms of profitability, HO1.DE's ROE is +0.08%, compared to ZIM.DE's ROE of +0.05%. Regarding short-term risk, HO1.DE is more volatile compared to ZIM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for HO1.DE.Check ZIM.DE's competition here

HO1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HO1.DE stands at 0. In comparison, 0HV.DE has a market cap of 0. Regarding current trading prices, HO1.DE is priced at €61.50, while 0HV.DE trades at €39.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HO1.DE currently has a P/E ratio of 86.74, whereas 0HV.DE's P/E ratio is N/A. In terms of profitability, HO1.DE's ROE is +0.08%, compared to 0HV.DE's ROE of +0.01%. Regarding short-term risk, HO1.DE is more volatile compared to 0HV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for HO1.DE.Check 0HV.DE's competition here